CareDx to Report Third Quarter 2021 Financial Results
CareDx, Inc. (Nasdaq: CDNA) is set to report its third quarter 2021 financial results on October 28, 2021, after market close. A conference call will follow at 1:30 p.m. PT/4:30 p.m. ET. Interested parties can join by calling 877-705-6003 or 201-493-6725, referencing Conference ID: 13724010. CareDx specializes in precision medicine solutions for transplant patients, providing a range of testing services and digital healthcare tools aimed at improving patient outcomes.
- CareDx is a leader in precision medicine solutions, focusing on the transplant patient market.
- None.
SOUTH SAN FRANCISCO, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it will report financial results for the third quarter 2021 after market close on Thursday, October 28, 2021. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Individuals interested in listening to the conference call may do so by dialing 877-705-6003 for domestic callers or 201-493-6725 for international callers. Please reference Conference ID: 13724010. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.
About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
CONTACTS:
CareDx, Inc.
Investor Relations
Ian Cooney
415-287-2300 x 3550
investor@caredx.com
FAQ
When will CareDx report its third quarter 2021 earnings?
What time is the CareDx conference call scheduled?